My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2021-109B
CBCC
>
Official Documents
>
2020's
>
2021
>
2021-109B
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
11/12/2021 3:40:26 PM
Creation date
11/12/2021 3:39:38 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Addendum
Approved Date
08/17/2021
Control Number
2021-109B
Agenda Item Number
8.M.
Entity Name
RxBenefits, Inc.
Subject
Addendum to Administrative Services Agreement for RxBenefits
and Express Scripts effective October 1, 2021
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
19
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
DocuSign Envelope ID: 5B185859-5943-4C41-90BF-OCE5E90FDAD D <br />(01/2021 Version) <br />Additional Administrative Services: Client will pay for additional administrative services (the "Additional <br />Administrative Services") beyond those included in the Base Administrative Services that are requested by <br />Client and provided or made available by Administrator under the program as follows: <br />2.1 Administrative Fees <br />The following terms and conditions apply only if client does not elect HDCR: <br />■ Initial determination — this is the first review of drug coverage based on the plan's conditions of <br />coverage. Initial determinations are also referred to as initial reviews, coverage reviews, prior <br />authorization reviews, UM reviews, or benefit reviews. <br />■ The Level 2 and Urgent Appeal Service is an optional service for Clients to enroll in and there is <br />an incremental fee of $10 per initial determination. <br />■ Level 2 and Urgent Appeals are not included in the UM package fees. <br />■ The Level 2 and Urgent Appeal Service fee is not charged per appeal. It is charged for each initial <br />review. This allows Client to better estimate their appeal costs since it is based on the number of <br />NOT FOR DISTRIBUTION. THE INFORMATION CONTAINED HEREIN IS CONFIDENTIAL, PROPRIETARY <br />AND CONSTITUTES TRADE SECRETS OF EXPRESS SCRIPTS AND RXBENEFITS <br />Adniinistrative Services <br />Transaction Fees Payable for Administrative Services (per <br />Fees <br />$0.65 per Prescription Drug Claim made <br />Article IV.B of the Agreement) <br />by Members payable on a bi-monthlybasis <br />Transaction Fees Payable for Administrator's Clinical <br />Advantage Program <br />individual prices listed in table below <br />$1.45 i2er claim <br />Manufacturer op.I)rograms <br />Fees <br />Not Elected <br />• Out of Pocket Protection Accumulation <br />• Out of Pocket Protection + Variable Copay <br />Not Elected <br />Assistance Program <br />• SaveOnSP <br />Not Elected <br />• Out of Pocket Protection + SaveOnSP <br />$0.40 per claim (Elected) <br />Reviews and Appeals <br />• Low Clinical Value Exclusions CV <br />$0.30 per claim (Elected) <br />• High Dollar Claim Review R <br />$0.75 per claim (Elected) <br />Initial Determinations (i.e. coverage reviews) and Level <br />Included in the existing utilization <br />One Non -Urgent Appeals for the Coverage Authorization <br />management PMPM charge <br />Program, consisting of: <br />OR <br />Prior Authorization <br />Step Therapy <br />Included in the existing PA charge of $55 <br />Drug Quantity Management <br />per initial determination* <br />OR <br />No Charge if Client elects HDCR <br />Initial Determinations and Level One Non -Urgent Appeals <br />$55 per initial determination <br />for benefit reviews. Examples: copay review, plan <br />OR <br />excluded drug coverage review, administrative plan design <br />review. <br />No Charge if Client elects HDCR <br />Final and Binding Appeals — Level Two Appeals and/or <br />$10.00 per review* <br />Urgent Appeals for UM, formulary, and benefit reviews. <br />OR <br />No Charge if Client elects HDCR <br />External Reviews by Independent Review Organizations - for <br />$800 per review <br />non -grandfathered plans <br />OR <br />No Charile if Client elects HDCR <br />Third Party Integration Fees <br />Charges passed through from provider or <br />mutually agreed upon by Parties <br />The following terms and conditions apply only if client does not elect HDCR: <br />■ Initial determination — this is the first review of drug coverage based on the plan's conditions of <br />coverage. Initial determinations are also referred to as initial reviews, coverage reviews, prior <br />authorization reviews, UM reviews, or benefit reviews. <br />■ The Level 2 and Urgent Appeal Service is an optional service for Clients to enroll in and there is <br />an incremental fee of $10 per initial determination. <br />■ Level 2 and Urgent Appeals are not included in the UM package fees. <br />■ The Level 2 and Urgent Appeal Service fee is not charged per appeal. It is charged for each initial <br />review. This allows Client to better estimate their appeal costs since it is based on the number of <br />NOT FOR DISTRIBUTION. THE INFORMATION CONTAINED HEREIN IS CONFIDENTIAL, PROPRIETARY <br />AND CONSTITUTES TRADE SECRETS OF EXPRESS SCRIPTS AND RXBENEFITS <br />
The URL can be used to link to this page
Your browser does not support the video tag.